← Back to Search

Minimum requirements camera for Healthy Humans

N/A
Waitlist Available
Research Sponsored by Philips Clinical & Medical Affairs Global
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up each participants will have measurement for 1 hour on 1 day. study will be completed within 1 week.
Awards & highlights

Study Summary

This Performance Assessment Study will focus on testing the performance of the VitalSigns Camera under various suboptimal use cases. The software makes it possible to measure the pulse rate (PR) and respiration rate (RR) without the device being in contact with the subject. The software delivers fast and accurate results (in less than one minute). Vital signs camera (VSC) product will be used via a demonstrator app on one of the smartphones during the study sessions (camera of the phone will be used by the VSC product). Devices will be provided by the researchers. The subject will be asked to perform a number of assignments with the software application. The study involves taking a number of measurements of the subject's PR using the VitalSigns Camera software application (which is installed on a smartphone or laptop). In this study only PR is measured and not RR as the latter parameter is not affected by the designed test cases. The total duration of the session will be approximately 1 hour. In total, approximately 30 healthy volunteers will participate in this study.

Eligible Conditions
  • Healthy Humans
  • Vital Sign Monitoring

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~each participants will have measurement for 1 hour on 1 day. study will be completed within 1 week.
This trial's timeline: 3 weeks for screening, Varies for treatment, and each participants will have measurement for 1 hour on 1 day. study will be completed within 1 week. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary endpoint

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy volunteersExperimental Treatment8 Interventions
1 arm. Healthy volunteers assigned to different interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Face mask
2020
Completed Phase 4
~350480

Find a Location

Who is running the clinical trial?

Philips Clinical & Medical Affairs GlobalLead Sponsor
48 Previous Clinical Trials
15,948 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~11 spots leftby Apr 2025